Sarilumab is another anti IL-6R monoclonal antibody that was repurposed for the management of severe COVID-19 (https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/761037s000lbl.pdf). The gene discussed is IL6R; the disease is COVID-19.